Newborn affected by noxious substances transmitted via placenta or breast milk P04
- P04 should not be used for reimbursement purposes. Please select a more specific diagnosis below.
- The 2019 edition of ICD-10-CM P04 became effective on October 1, 2018.
- This is the American ICD-10-CM version of P04 - other international versions of ICD-10 P04 may differ.
Type 2 Excludes:
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
- nonteratogenic effects of substances transmitted via placenta
Codes: = Billable
P04 Newborn affected by noxious substances transmitted via placenta or breast milk
- P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
- P04.1 Newborn affected by other maternal medication
- P04.2 Newborn affected by maternal use of tobacco
- P04.3 Newborn affected by maternal use of alcohol
- P04.4 Newborn affected by maternal use of drugs of addiction
- P04.5 Newborn affected by maternal use of nutritional chemical substances
- P04.6 Newborn affected by maternal exposure to environmental chemical substances
- P04.8 Newborn affected by other maternal noxious substances
- P04.9 Newborn affected by maternal noxious substance, unspecified
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.